Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
TMCnet

Terray's New EMMI Predict Model Sets an Industry Performance Standard - Delivering Best-In-Class Accuracy, 26x Faster

Terray Therapeutics today unveiled the latest EMMI prediction model, a universal potency model that outperforms the industry: ...
FierceBiotech

Nvidia unveils generative AI programs for drug molecule design, protein predictions

A little more than a year after announcing plans for its molecule design programs to set up shop in the field of generative AI, Nvidia is opening its doors. Just as call-and-response apps like ChatGPT ...
TMCnet

Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a computational chemistry company focused on AI-driven small-molecule design for the pharmaceutical and agricultural industries, today announced an expanded ...
Science Daily

Chemists develop new method for making gamma chiral centers on simple carboxylic acids

C-H activation-based method should speed drug molecule design and diversification. Scripps Research chemists have accomplished a long elusive feat in synthetic chemistry: the invention of a broadly ...
Business Wire

insitro Partners with Lilly to Build First-in-Kind Machine Learning Models to Advance Small Molecule Drug Discovery

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
Seeking Alpha

Design Therapeutics to Present Preclinical Data on its GeneTAC™ Small Molecule, DT-168, for the Treatment of Fuchs Endothelial Corneal Dystrophy at ARVO 2023

CARLSBAD, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today ...